key: cord-0031406-7qdfe99g authors: Zuo, Wei; Yu, Xing-Xing; Liu, Xue-Fei; Chang, Ying-Jun; Wang, Yu; Zhang, Xiao-Hui; Xu, Lan-Ping; Liu, Kai-Yan; Zhao, Xiao-Su; Huang, Xiao-Jun; Zhao, Xiang-Yu title: The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation date: 2022-04-29 journal: Front Immunol DOI: 10.3389/fimmu.2022.814334 sha: ffc132be87f4b57d30351379eb4c558c8d7c920a doc_id: 31406 cord_uid: 7qdfe99g NKG2C+ natural killer (NK) cell plays a vital role in CMV infection control after hematopoietic stem cell transplantation (HSCT). However, the modulation on NKG2C+ NK cell reconstitution is still unclear. NK cell education is affected by the interactions of HLA-I/killer immunoglobulin receptor (KIR). Our aim is to figure out which HLA-I/KIR interaction plays a dominant role in NKG2C+ NK education. Based on allogeneic haploidentical HSCT, we investigated the expansion and function of single KIR positive NKG2C+ NK cells via the interaction of KIR with both donor HLA and recipient HLA at days 30, 90, and 180 after HSCT. KIR2DL2/L3 single-positive/NKG2C(+) cells were significantly expanded compared with KIR2DL1 or KIR3DL1 single-positive/NKG2C(+) cells when donors and recipients were both HLA-C1/C1 or HLA-C1C1BW4 (p < 0.05), with higher NKp30 expression (p < 0.05). Moreover, the proportion of single KIR positive NK cells increased in both NKG2C(+)/NKG2A(-) NK cells and conventional NKG2C(-)/NKG2A(-) NK cells over time. We also observed that increased proportion of KIR2DL2/L3 single-positive/NKG2C(+) NK cells correlated with higher incidence of acute graft-versus-host disease (aGVHD). Our study allows a better understanding of HLA-I/KIR interaction in the NKG2C+ NK cell education after HSCT. Natural killer (NK) cells are lymphocytes involved in innate immunity that respond to viral infections and tumor cells; they are the first reconstituting lymphocytes after stem cell transplantation (1) and are related to clinical outcomes after hematopoietic stem cell transplantation (HSCT) (2) . For NK cells to be functional, they must acquire inhibitory receptors that recognize self-HLA-I (3), which makes them tolerant of healthy cells but responsive to unhealthy cells with reduced expression of HLA class I, a process called "NK cell education" or "NK cell licensing" (3) (4) (5) (6) . Antibody-independent cytotoxicity of NK cells was activated by an imbalance between activating and inhibitory signals from the interactions between NK cell receptors and their ligands (7, 8) , including the killer immunoglobulin-like receptors (KIRs), natural cytotoxicity receptors (NCRs), and Natural Killer Group (NKG)2x receptors (9) (10) (11) (12) . NK cell education was mainly affected by interaction of HLA-E/NKG2A and KIR/HLA (13) (14) (15) . HLA-E polymorphism has an impact on relapse and disease-free survival in patients after HSCT (16, 17) . It is revealed that NKG2A/CD94+ NK cells generated HSCT, which are blocked at an immature state with impaired functioning, and also have a potential negative impact on immune responsiveness and transplantation outcome (15, 18) . Moreover, the upregulated interaction of HLA-E/NKG2A after HSCT was associated with poorer NK cytolysis and higher transplantation-related mortality (19, 20) . Although NKG2A/HLA-E can also affect NK education and clinical outcomes (15, 16, 21) , this study mainly focused on KIR/HLA-I interaction on NKG2C+ NK cells, which might be biased and not all-inclusive. During NK cell education, NK subset expansion is tuned to be commensurate with the number of self-inhibitory receptors as well as by the presence of HLA ligand (22) . Additionally, the expression of KIR receptors is influenced by extensive sequence polymorphisms of KIR genes (23) , and promoter polymorphisms are obvious modifiers of transcription (24) , altering expression (25) . In healthy people, co-expression of HLA-C2 diminishes the cell surface density of KIR2DL1 on NK cells instead of impacting the respective frequencies of KIR2DL1-expressing cells within the NK repertoire (6, (26) (27) (28) . On the contrary, another study found that individuals with KIR2DL1 or KIR3DL1 have greater numbers of NK cells expressing these genes if the HLA-C2 or HLA-Bw4 ligands are, respectively, present in the individuals (25, 29) . Moreover, HLA-C1 ligands also affect the size of a subset of KIR2DL2/L3 + NK cells (30) . Additionally, in the setting of allogeneic transplantation, NK reconstitution is affected by the HLA of recipients and/or donors. Our previous study demonstrated that when both donors and hosts presented all KIR ligands (HLA-C1, HLA-C2, and HLA-Bw4) and NK cells expressed 3 inhibitory receptors (KIR2DL1, KIR2DL2/L3, and KIR3DL1), the reconstituted NK cells achieved better education and contributed to the lowest rate of relapse among the patients (31, 32) . In addition, different KIR/HLA-I interactions can act through NK cell licensing to generate different levels of intrinsic responsiveness. The "Rheostat model" predicted weaker licensing by HLA-C1/KIR2DL2/L3 interactions than HLA-C2/ KIR2DL1 (33, 34) . Another study revealed that KIR2DL2/L3 and KIR2DL1 have similar capacities to licence NK cells (35) . Therefore, the effect of the affinity of existing HLA-C ligands to cognate KIRs on NK licensing is still unclear, suggesting that the inhibitory signal strength and amount of available HLA-C ligands both influence NK cell education. NKG2C is an activating receptor on the surface of NK cells that binds to antigen peptides presented by HLA-E molecules on the surface of target cells to activate NK cell functions (1, 21, (36) (37) (38) . Recent studies have shown that NKG2C + NK cells expanded distinctively with enhanced effector functions when stimulated by cytomegalovirus. These NK cells adapt to a pathogen and deliver a more potent recall response, called adaptive NK cells (4, 6, 39) . NKG2C and the KIR family may participate in the NKG2C + NK cell response. In human cytomegalovirus (HCMV)-seropositive patients, only NKG2C + NK cells expressing KIR that recognized self-MHC ligands are hyperresponsive and make IFN-g (40) , suggesting that NKG2C + NK cells are composed mainly of educated NK cells. Obvious NKG2C + NK cell expansions tend to be dominated by a single KIR clone, which is directed towards HLA-C-specific KIR encoded by the centromeric part of group A (CenA) haplotypes, but the moderately expanded NKG2C + NK cells are often polyclonal (41) . Group A haplotype encoded inhibitory KIR for all three major HLA class I, such as KIR2DL1 and KIR2DL3 on the centromeric part, specific for the HLA-C2 and -C1 epitopes, and HLA-Bw4 on the telomeric part, specific for KIR3DL1 (41, 42) . A study of a cohort of HCMV serum-positive patients revealed that the expression of KIR2DL1 on NKG2C + NK cells led to significantly larger clonal expansion than KIR2DL2, suggesting that an interaction of KIR2DL1 and HLA-C2 ligands seems to promote the expansion of NKG2C + NK cells in response to HCMV infection (41) . Another cohort of patients with HCMV infection post-transplantation was found to have expansion of NKG2C + NK cells accompanied by coexpression of KIR with a strong bias towards KIR2DL2/L3; moreover, none of these patients expressed HLA-C1 as their only self-ligand (43) . These studies revealed that under HCMV infection, the expansion of NKG2C + NK cells showed a bias towards KIR2DL1 or KIR2DL2 expression due to the interaction between HLA-C and KIRs. However, previous studies did not focus on single KIR-positive NK cells without eliminating the interference of the interaction of other KIRs/ligands. In the posttransplantation setting, the interaction of donor and recipient KIR ligands in NKG2C + NK cell education is still not clear. Based on the haploidentical transplantation setting, we explored NKG2C + NK cell reconstitution among patients post transplantation and creatively studied the proportion of singlepositive KIR NK cells among the NKG2C + NK cells to exclude the interference of other KIRs. Additionally, we also explored whether the number and type of KIRs (KIR2DL2/L3, KIR2DL1, and KIR3DL1) affect NKG2C + expansion and, whether under different donor/recipient HLA types, the expansion, cytotoxicity function, and key molecules of single-positive KIR NK cells vary among NKG2C + NK cells. We observed that KIR2DL2/L3 single NK cells were significantly expanded among NKG2C + NK cells compared with KIR2DL1 and KIR3DL1. Furthermore, we investigated whether the genotype of NKG2C would affect KIR2DL2/L3 single KIR NK cell expansion among NKG2C + NK cells and whether it would be related to the clinical outcomes of HCMV reactivation. The prospective cohort included 128 patients with malignant hematologic disease who underwent HSCT at Peking University People's Hospital between May 2016 and April 2017. The patient characteristics of the cohort are described in Table 1 . All patients and donors provided written informed consent. The individuals of the cohort, who met the criterion that both recipients and donors were HCMV sero-positive before transplantation and recipients are HCMV-reactivated post allo-HSCT, were defined as "HCMVreactivating" individuals. We also described the HLA-C status of the patients in cohort in Table 2 .The flow chart of cohort enrolment is presented in Supplementary Figure 5 . This study was approved by the Institutional Review Committee of the Institute of Haematology, Peking University, and it was registered at www. clinicaltrials.gov (NCT02978274). Quantitative and qualitative reconstructions of NK cells were performed at 30, 90, and 180 days after transplantation. All patients received myeloablative regimens (44, 45) . Pretransplant conditioning was performed with cytarabine (4 g/m 2 per day on Days −8 to −9), busulfan (3.2 mg/kg per day IV on Days −8 to −6), cyclophosphamide (1.8 g/m 2 per day on Days −5 to −4), semustine (250 mg/m 2 on Day −3), and rabbit anti-thymocyte globulin (thymoglobulin; Imtix Sangstat, Lyon, France; 2.5 mg/kg per day IV on Days −5 to −2) (44, 46) . GVHD prophylaxis was performed with cyclosporine, mycophenolate mofetil, and short-course methotrexate, as previously described (44, 46) . The transplant procedure was performed as previously described (31, 47, 48) . Patient and donor DNA was prepared from peripheral blood mononuclear cells (PBMCs) from fresh blood samples for pretransplant HLA typing and stored at −40°C. Molecular HLA typing and KIR genotyping were performed (One Lambda, Canoga Park, CA) in accordance with the manufacturer's instructions. HLA-C and HLA-B alleles were identified with high-resolution DNA-based HLA typing and segregated into the following epitope groups: HLA-C group 1 (HLA-CAsn80: HLA-Cw1, 3, 7, 8, 13, and A real-time polymerase chain reaction (PCR) kit from Shenzhen PG Biotechnology Co., Ltd., China was used to detect HCMV reactivation through plasma HCMV DNA detection twice a week. HCMV infection was diagnosed according to previously published criteria (49) (50) (51) , which means HCMV DNA ≥ 1 × 10 3 copies/ml in peripheral blood based on the HCMV PCR assay. Refractory reactivation was defined as HCMV reactivation lasting over 2 weeks (51, 52). Donor DNA was isolated from total fresh blood samples using the Puregene Blood Core kit B (Qiagen), and NKG2C zygosity was assessed as previously described (53) . The patients were divided into NKG2C del/del , NKG2C wt/wt , and NKG2C wt/del groups according to the donor genotype. Surface marker staining of PBMCs from patients' fresh blood samples for the following markers was performed in PBS at 4°C for 30 min following , and IFN-g (BioLegend, B27). Acquisition was performed on an LSR Fortessa instrument (BD Biosciences), and Flowjo software (TreeStar) was used for analysis. Single-stain controls for compensation were generated utilizing UltraComp eBeads (eBioscience, BioLegend, and Miltenyi Biotec), and the analysis of acquired samples was performed in FlowJo (FlowJo, LLC, Ashland, CA) data analysis software. Data were gated using FlowJo (FlowJo, LLC). Following data acquisition, the channel intensity was normalized using calibration beads. Before the experiment, we verified the configuration by selecting an appropriate configuration and defining a new baseline every 24 h. We set up and ran a performance check. The anti-human monoclonal antibodies used for flow cytometry are listed in Supplementary Table 1 . The cytotoxicity test used cryopreserved PBMC samples from patients. Two million freshly thawed PBMCs were washed twice and transferred to a 96-well round-bottom plate (Corning) with RPMI 1640 supplemented with 10% fetal calf serum and 1,000 IU/ml interleukin 2 (IL-2; Beijing Double-Crane Pharmaceutical Co., Ltd.) for 10-14 h. PBMCs were cultured in preparation for both spontaneous and IL-2-stimulated NK cytotoxicity assays. The cytotoxicity and cytokine secretion of the NK cells was determined by CD107a and IFN-g expression against the target K562 cells at an effector-to-target ratio of 5:1 for 4 h, with GolgiStop (0.7 µl/ml, BD Biosciences) added after 1 h to trap proteins in the cytoplasm. After fixation and permeabilization of PBMCs using a Pharmingen Intracellular Staining kit (BD Pharmingen, San Diego, CA, USA) for 40 min at 4°C, we washed it twice and added the IFN-g antibody. Continuous variables were compared using a nonparametric test (Mann-Whitney U test for two groups and Kruskal-Wallis H test for multiple groups) and parametric tests (two-sample t-test, paired t-test, and one-way analysis of variance). The association between the proportion of KIR2DL2/L3 single-positive/NKG2C + NK cells and clinical outcomes and HCMV reactivation type was analyzed by the chi-square test. ROC curve was used to get the cutoff value. We used Cox regression analysis to perform univariate and multivariate analyses. Variables with p < 0.10 in univariate analysis were further included in the multivariate analysis. The cumulative incidence of acute graft-versus-host disease (aGVHD) was estimated using the competing risk model by R software 4.1.1. Statistical analyses were performed using SPSS 26.0 and GraphPad Prism 8.0. p-values < 0.05 were considered statistically significant. To determine whether the number and types of KIR ligands influence NKG2C + NK cell expansion, phenotype, or cytotoxicity We showed the HLA-C status of recipients and donors who had the same HLA-C as their corresponding donors. function, we divided the patients into 4 groups (groups W, X, Y, and Z) according to the number of KIR ligands shared by donors and recipients, and divided the patients into 6 groups (group A to group F) according to the types of KIR ligand presented by both donor and recipient. The proportion of NKG2C + NK cells among the NK cells, the absolute number of NKG2C + NK cells, and the expression of NKp30, NKp46, and DNAM-1 and secretion of IFNg and CD107a by NK cells were analyzed among groups W to Z and among groups A to F. Group W included donors and recipients who were C2C2BW4×C1C1 or C1C1BW4×C2C2, which shared a 0 ligand matches; group X included donors and recipients who were C1C1BW4×C2C1 or C2C2BW4×C2C1, which shared 1 ligand match; group Y included donors and recipients who were C1C1BW4×C1C1BW4, C2C2BW4×C2C2BW4, or C1C2×C1C2, which shared 2 ligand matches; and group Z included donors and recipients who were C1C2BW4×C1C2BW4, which shared 3 ligand matches. Group W did not undergo statistical analysis because their sample sizes were too small ( Figures 1A-F) . In group A, donors and recipients both presented HLA-C1, where donor recipients were C1C1×C1C1, C1C1×C1C1BW4, or C1C1×C1C2. In group B, donors and recipients both presented HLA-C2, where donor recipients were C2C2×C2C2, C2C2×C2BW4, or C2C2×C1C2. In group C, donors and recipients both presented HLA-BW4, and were C1C1BW4×C2BW4. In group D, donors and recipients both presented HLA-C1 and HLA-BW4, and donor recipients were C1C1BW4×C1C1BW4 or C1C1BW4×C1C2BW4. In group E, donors and recipients both presented HLA-C2 and HLA-BW4, and donor recipients were C2C2BW4×C2C2BW4 or C2C2BW4-C1C2BW4. In group F, donors and recipients both presented HLA-C1, C2, and HLA-BW4, and were both C1C2BW4. Group B and group C did not undergo statistical analysis because their sample sizes were too small ( Figures 1G-L) . In the cohort and in CMV-reactivated individuals, we found that there were no obvious differences among groups X, Y, and Z and among groups A, D, E, and F, regarding the proportion of NKG2C + NK cells among the NK cells or the absolute number of NKG2C + NK cells (cells/ml) on days 30, 90, and 180. Moreover, the expression of NKp30, NKP46, and DNAM-1 and the cytotoxicity function measured by IFN-g and CD107a were comparable among groups X to Z and among groups A, D, E, and F on days 30, 90, and 180. These results indicated that the number and types of KIR ligands shared by donors and recipients were irrelevant to NKG2C + expansion, expression of receptors, and cytotoxicity during NK cell education. The Presence of HLA-C1 Enhanced the Expansion of KIR2DL2/3 Single-Positive NKG2C + NK Cells, With Increased Expression of NKp30 To evaluate whether the HLA-C/KIR interaction will affect the expansion of NK subsets, according to the combination of donor-recipient KIR ligands, we divided the patients into 3 groups, where the donor and recipient were both C1C1 in group 1, C1C1BW4 in group 2, and C1C2BW4 in group 3. We analyzed the percentage of the three NK cell populations expressing 1 specific KIR among the NKG2C + NK cells and the expression levels of NKp30, NKP46, and DNAM-1. Gating strategy was described in Supplementary Figure 1 . On days 90 and 180, in the whole cohort, the proportion of KIR2DL2/L3 single-positive/NKG2C + NK cells among the NKG2C + NK cells was higher than those of KIR2DL1 and KIR3DL1, in group 1 ( Table 3) , which suggested that the existence of a combination of HLA-C1 and KIR2DL2/L3 enhanced the KIR single-positive NK cell expansion (Figures 2A, C) . However, in group 3, the proportions of KIR2DL2/L3 and KIR2DL1 single-positive/NKG2C + cells were both higher than that of KIR3DL1 cells ( Table 3) , demonstrating that the coexistence of both donor and host HLA-C1 or HLA-C2 was conducive to stronger expansion of KIR single-positive NK cells than HLA-BW4 (Figures 2A, C) . In addition, the MFI of NKp30 expression on KIR2DL2/L3 single-positive/NKG2C + NK cells was significantly higher than that of the KIR2DL1 singlepositive/NKG2C + and KIR3DL1 single-positive/NKG2C + , in group 1 ( Figures A, C) , group 2, and group 3 (Figures 2B, D) ( Table 3) , which indicated that the combination of KIR2DL2/L3 single-positive/NKG2C + and HLA-C1 significantly correlated with a higher expression level of NKp30. We additionally analyzed the expansion and function of single-positive NK cells in individuals in the cohort screened by the criteria that both recipients and donors are HCMV seropositive before transplantation and recipients are HCMV viruspositive post allo-HSCT, called HCMV-reactivating individuals. In HCMV-reactivating individuals, on days 90 and 180, the proportion of KIR2DL2/L3 single-positive/NKG2C + NK cells among NKG2C + NK cells was consistently higher than that of KIR2DL1 and KIR3DL1 NK cells (data not shown), which suggested that HCMV infection might not affect the expansion of KIR2DL2/L3 single-positive/NKG2C + NK cells. These results further demonstrated that the integration of KIR2DL2/L3 single-positive/NKG2C + and HLA-C1 cells mainly contributed to NKG2C + NK cell education, including KIR singlepositive NK cell expansion and activating receptor expression. Additionally, KIR single-positive NK cells showed comparable functions of cytotoxicity. There were no significant differences in CD107a expression or IFN-g secretion among Figure 3) . The data indicated that three NK cell populations expressing 1 specific KIR had comparable reactivity. Similarly, in the HCMVreactivating individuals, the same results were observed (data not shown). We further analyzed the expansion of KIR2DL1, KIR2DL2/ L3, or KIR3DL1 single-positive NK cells in another group, in which either the donor or recipient was C1. We observed that on days 30 (p = 0.186), 90 (p = 0.108), and 180 (p = 0.046), Considering that NKG2C expression on NK cells could be influenced by NKG2C genotyping (54, 55), we further analyzed the effect of donor NKG2C genotyping on KIR single-positive/ NKG2C+ NK cell expansion. We found that in both the NKG2C wt/del and NKG2C wt/wt groups, the percentage of KIR2DL2/L3 single-positive/NKG2C + NK cells among the NKG2C + NK cells was significantly higher than single-KIR2DL1 + /NKG2C + and single-KIR3DL1 + /NKG2C + NK cells on days 90 and 180 in the whole cohort ( Supplementary Figures 4A-C) and in HCMV-reactivating individuals (data not shown). We also found that the percentage of KIR2DL2/L3 single-positive/NKG2C + NK cells among the NKG2C + NK cells between the NKG2C wt/wt and the NKG2C wt/del groups were comparable in both the whole cohort and in HCMVreactivating individuals, indicating that NKG2C genotype did not influence the expansion of KIR2DL2/L3 single-positive/ NKG2C + NK cells (Supplementary Figures 4A-D) . infection promoted KIR2DL3 single-positive/NKG2C+ NK cell expansion in the CenA/B group. The detailed associations among the KIR2DL2/L3 singlepositive/NKG2C + proportion, HCMV infection type (no refractory reactivation and refractory reactivation), clinical outcomes (no relapse and relapse, death, or survival), and duration of viremia are presented in Table 1 . According to the median proportion of KIR2DL2/L3 single-positive/NKG2C + NK cells among the NKG2C + cells, we divided the recipients into a strong KIR2DL2/L3 single-positive/NKG2C + expansion group (>median, day 30 = 10.81%, day 90 = 18.31%, day 180 = 21.19%) and a weak KIR2DL2/L3 single-positive/NKG2C + expansion group (cutoff value = 20.09%) and a weak group ( 20.09%, n = 69, red line; KIR2DL2/L3 single positive/NKG2C+ NK cells < 20.09%, n = 27, blue line) after HSCT. Natural Killer Cells Play an Important Role in Virus Infection Control: Antiviral Mechanism, Subset Expansion and Clinical Application Immune Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation Human NK Cell Education by Inhibitory Receptors for MHC Class I Strategies to Activate NK Cells to Prevent Relapse and Induce Remission Following Hematopoietic Stem Cell Transplantation MHC Class I-Specific Inhibitory Receptors and Their Ligands Structure Diverse Human NK-Cell Repertoires Toward a Balance of Missing Self-Response Influence of KIR Gene Copy Number on Natural Killer Cell Education Balancing Natural Killer Cell Activation Through Paired Receptors Natural Killer Cell Signaling Pathways Exhausted NK Cells and Cytokine Storms in COVID-19: Whether NK Cell Therapy Could be a Therapeutic Choice Activation, Coactivation, and Costimulation of Resting Human Natural Killer Cells Activating and Inhibitory Receptors of Natural Killer Cells Natural Killer Cells: Development, Maturation, and Clinical Utilization Up-Regulation of Activating and Inhibitory NKG2 Receptors in Allogeneic and Autologous Hematopoietic Stem Cell Grafts Reconstitution of NK Cell Receptor Repertoire Following HLA-Matched Hematopoietic Cell Transplantation NK-Cell Reconstitution After Haploidentical Hematopoietic Stem-Cell Transplantations: Immaturity of NK Cells and Inhibitory Effect of NKG2A Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome The Impact of HLA-E Polymorphisms on Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation NK Cell Maturation to CD56(dim) Subset Associated With High Levels of NCRs Overrides the Inhibitory Effect of NKG2A and Recovers Impaired NK Cell Cytolytic Potential After Allogeneic Hematopoietic Stem Cell Transplantation Reconstitution of Natural Killer Cell Receptor Repertoires After Unmanipulated HLA-Mismatched/ Haploidentical Blood and Marrow Transplantation: Analyses of CD94: NKG2A and Killer Immunoglobulin-Like Receptor Expression and Their Associations With Clinical Outcome HLA-E Upregulation on IFN-Gamma-Activated AML Blasts Impairs CD94/NKG2A-Dependent NK Cytolysis After Haplo-Mismatched Hematopoietic SCT HLA-E Binds to Natural Killer Cell Receptors CD94/NKG2A, B and C The Killer Cell Immunoglobulin-Like Receptor (KIR) Genomic Region: Gene-Order, Haplotypes and Allelic Polymorphism Killer Cell Immunoglobulin-Like Receptors on NK Cells: The How, Where and Why KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand The Extensive Polymorphism of KIR Genes Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation 2DL2 and 2DL3 All Contribute to KIR Phenotype Variability on Human NK Cells Roles for HLA and KIR Polymorphisms in Natural Killer Cell Repertoire Selection and Modulation of Effector Function HLA-Cw7 Zygosity Affects the Size of a Subset of CD158b+ Natural Killer Cells Donor and Host Coexpressing KIR Ligands Promote NK Education After Allogeneic Hematopoietic Stem Cell Transplantation Recipient Expression of Ligands for Donor Inhibitory KIRs Enhances NK-Cell Function to Control Leukemic Relapse After Haploidentical Transplantation NK Cell Education: Not an On-Off Switch But a Tunable Rheostat The Strength of Inhibitory Input During Education Quantitatively Tunes the Functional Responsiveness of Individual Natural Killer Cells KIR2DL3 and KIR2DL1 Show Similar Impact on Licensing of Human NK Cells Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus Gpul40 Expansion of CD94/NKG2C+ NK Cells in Response to Human Cytomegalovirus-Infected Fibroblasts Natural Killer Cell Specificity for Viral Infections About Training and Memory: NK-Cell Adaptation to Viral Infections Natural Killer (NK) Cells Respond to CMV Reactivation After Allogeneic Transplantation With An Increase in NKG2C(+)CD57(+) Self-KIR+ NK Cells With Potent IFN Gamma Production KIR Polymorphism Modulates the Size of the Adaptive NK Cell Pool in Human Cytomegalovirus-Infected Individuals Cytomegalovirus Reactivation After Allogeneic Transplantation Promotes a Lasting Increase in Educated NKG2C+ Natural Killer Cells With Potent Function Haploidentical vs Identical-Sibling Transplant for AML in Remission: A Multicenter, Prospective Study Who is the Best Donor for a Related HLA Haplotype-Mismatched Transplant? Haploidentical Transplant for Myelodysplastic Syndrome: Registry-Based Comparison With Identical Sibling Transplant Quantitative Chimerism: An Independent Acute Leukemia Prognosis Indicator Following Allogeneic Hematopoietic SCT Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands Patients With Refractory Cytomegalovirus (CMV) Infection Following Allogeneic Haematopoietic Stem Cell Transplantation Are at High Risk for CMV Disease and non-Relapse Mortality Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients Assessment of Copy-Number Variation in the NKG2C Receptor Gene in a Single-Tube and Characterization of a Reference Cell Panel, Using Standard Polymerase Chain Reaction Relationship of NKG2C Copy Number With the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets NKG2C Zygosity Influences CD94/NKG2C Receptor Function and the NK-Cell Compartment Redistribution in Response to Human Cytomegalovirus Analyses of HLA-C-Specific KIR Repertoires in Donors With Group A and B Haplotypes Suggest a Ligand-Instructed Model of NK Cell Receptor Acquisition Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells Functional Competence of NK Cells via the KIR/MHC Class I Interaction Correlates With DNAM-1 Expression Inhibition of the NKp30 Activating Receptor by Pp65 of Human Cytomegalovirus Amplified NKG2C+ NK Cells in Cytomegalovirus (CMV) Infection Preferentially Express Killer Cell Ig-Like Receptor 2DL: Functional Impact in Controlling CMV-Infected Dendritic Cells The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells KIR and HLA Interactions are Associated With Control of Primary CMV Infection in Solid Organ Transplant Recipients HLA-A Alleles Influencing NK Cell Function Impact AML Relapse Following Allogeneic Hematopoietic Cell Transplantation Single-Cell Profiling Identifies Impaired Adaptive NK Cells Expanded After HCMV Reactivation in Haploidentical HSCT Prognosis After Unmanipulated HLA-Haploidentical Blood and Marrow Transplantation Is Correlated to the Numbers of KIR Ligands in Recipients The Beneficial Role of Inhibitory KIR Genes of HLA Class I NK Epitopes in Haploidentically Mismatched Stem Cell Allografts May Be Masked by Residual Donor-Alloreactive T Cells Causing GVHD Evaluation of KIR Ligand Incompatibility in Mismatched Unrelated Donor Hematopoietic Transplants. Killer Immunoglobulin-Like Receptor The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.